A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Financial Summary
| Share Statistics | PLRZ | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $19.6 | $286.3 | 10% |
|
| Shares Out (Mil) | 1.1 | 54.2 | 5% |
|
| Institutional Ownership | 12.9% | 92.8% | 8% |
|
| Float (Mil) | 1.6 | 39.7 | 4% |
|
| Beta | na | 0.94 | na |
|
| Avg Daily Volume (000s) | 76 | 534 | 32% |
|
| Price Change (52-week) |
69.7% | 58.7% | 85% |
|
| Growth | PLRZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | (101.2%) | (10.1%) | 2% |
|
| EPS (5yr) | na | 16.0% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | PLRZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($3) | ($43) | 35% |
|
| EPS (TTM) | ($4.902) | ($1.400) | 8% |
|
| Operating Cash Flow (TTM) (Mil) | ($5) | ($31) | 25% |
|
| Net Cash Flow (TTM) (Mil) | ($1) | $2 | 39% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $7 | $160 | 7% |
|
| Valuation | PLRZ | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.80 | 2.77 | 15% |
|
| P/E | na | 19.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | PLRZ | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 64.2% | na |
|
| Net Margin | na | (75.9%) | na |
|
| ROA | (24.7%) | (47.3%) | 18% |
|
| ROE | (25.4%) | (55.0%) | 21% |
|
| Liabilities to Assets | 2.1% | 29.6% | 1% |
|
| F-Score | 2 | 2 | na |
|
Polyrizon Ltd. did not pass any screens on 8/20/2026.
